Oliver Schnell
Friedrich-Alexander-Universität Erlangen-Nürnberg
ORCID: 0000-0002-1284-1427Also affiliated with Universitätsklinikum Erlangen
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials”.
Kailei Nong, Per Olav Vandvik, Gordon H Guyatt, Oliver Schnell, Lars Rydén +35 more
Jacob S. Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino +25 more
Patrick Süß, Alexander Benkendorff, Chotima Böttcher, Camila Fernández‐Zapata, Chintan Chhatbar +15 more
Lisa I. Wadiura, Devin Juros, Misha Movahed-Ezazi, Matthew Lee, Hannah Weiss +31 more
Felix Sümpelmann, Wentao Dong, Eshaan S. Rawat, Inés Fernández-Maestre, Dongdong Fu +17 more
Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell +44 more
Thomas Zeyen, Uwe Schlegel, Lazaros Lazaridis, Jan‐Michael Werner, Julia Onken +38 more